{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:03:25Z","timestamp":1791291805925,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nefroe.2026.501473","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:06Z","timestamp":1773838506000},"page":"501473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing chronic kidney disease care through risk prediction: A review of the kidney failure risk equation"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-4446","authenticated-orcid":false,"given":"Bernardo","family":"Marques da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ant\u00f3nio Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gameiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501473_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2026.501473_bib0270","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2026.501473_bib0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072860","article-title":"The gap between estimated incidence of end-stage renal disease and use of therapy","volume":"8","author":"Anand","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2026.501473_bib0280","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2026.501473_bib0285","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2026.501473_bib0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.nefroe.2026.501473_bib0295","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501473_bib0300","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117722782","article-title":"Risk-based triage for nephrology referrals using the kidney failure risk equation","volume":"4","author":"Hingwala","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0305","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/gft063","article-title":"Validation of the kidney failure risk equation in European CKD patients","volume":"28","author":"Peeters","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501473_bib0310","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12882-021-02402-1","article-title":"A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility","volume":"22","author":"Ali","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0315","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2215\/CJN.03940320","article-title":"Performance of the kidney failure risk equation by disease etiology in advanced CKD","volume":"15","author":"Hundemer","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0320","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2023.03.014","article-title":"Utility of the kidney failure risk equation and estimated GFR for estimating time to kidney failure in advanced CKD","volume":"82","author":"Chu","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0325","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae321","article-title":"Adding biomarker change information to the kidney failure risk equation improves predictive ability for dialysis dependency in eGFR <30ml\/min\/1.73m2","volume":"17","author":"Okada","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2026.501473_bib0330","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.ekir.2021.09.006","article-title":"The effect of age on performance of the kidney failure risk equation in advanced CKD","volume":"6","author":"Hundemer","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2026.501473_bib0335","article-title":"The kidney failure risk equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts","volume":"26","author":"Grams","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0340","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.kint.2018.01.009","article-title":"Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate","volume":"93","author":"Grams","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501473_bib0345","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/ndt\/gfz018","article-title":"Towards the best kidney failure prediction tool: a systematic review and selection aid","volume":"35","author":"Ramspek","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501473_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100440","article-title":"Independent external validation and comparison of death and kidney replacement therapy prediction models in advanced CKD","volume":"4","author":"Thanabalasingam","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.nefroe.2026.501473_bib0355","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.08110715","article-title":"External validation of the kidney failure risk equation and re-calibration with addition of ultrasound parameters","volume":"11","author":"Lennartz","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002955","article-title":"The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study","volume":"16","author":"Major","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.nefroe.2026.501473_bib0365","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-019-1643-0","article-title":"Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia","volume":"20","author":"Wang","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0370","doi-asserted-by":"crossref","first-page":"313","DOI":"10.11622\/smedj.2020170","article-title":"Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort","volume":"63","author":"Kwek","year":"2022","journal-title":"Singapore Med J"},{"key":"10.1016\/j.nefroe.2026.501473_bib0375","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nefro.2022.03.003","article-title":"Validation of the kidney failure risk equation in a Portuguese cohort","volume":"43","author":"da Silva","year":"2023","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2026.501473_bib0380","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076217","article-title":"Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study","volume":"14","author":"Bravo-Z\u00fa\u00f1iga","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.nefroe.2026.501473_bib0385","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40620-023-01819-1","article-title":"External validation of the KFRE and Grams prediction models for kidney failure and death in a Spanish cohort of patients with advanced chronic kidney disease","volume":"37","author":"Gallego-Valcarce","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0390","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41512-023-00157-x","article-title":"Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study","volume":"7","author":"Maher","year":"2023","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.nefroe.2026.501473_bib0395","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nefroe.2025.05.003","article-title":"Multicenter validation of the kidney failure risk equation (KFRE) formula in Spanish patients with advanced chronic kidney disease","volume":"45","author":"Escamilla-Cabrera","year":"2025","journal-title":"Nefrolog\u00eda (Engl Ed)."},{"key":"10.1016\/j.nefroe.2026.501473_bib0400","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120911274","article-title":"Prediction of progression in polycystic kidney disease using the kidney failure risk equation and ultrasound parameters","volume":"7","author":"Akbari","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190930","article-title":"Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy","volume":"13","author":"Yamanouchi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2026.501473_bib0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753901","article-title":"A validation study comparing risk prediction models of IgA nephropathy","volume":"12","author":"Ouyang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0415","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117705372","article-title":"Validation of the kidney failure risk equation in Manitoba","volume":"4","author":"Whitlock","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0420","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ekir.2021.05.031","article-title":"Impact of using risk-based stratification on referral of patients with chronic kidney disease from primary care to specialist care in the United Kingdom","volume":"6","author":"Bhachu","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2026.501473_bib0425","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/imj.16377","article-title":"Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care","volume":"54","author":"Li","year":"2024","journal-title":"Intern Med J"},{"key":"10.1016\/j.nefroe.2026.501473_bib0430","series-title":"Chronic kidney disease: assessment and management","year":"2021"},{"key":"10.1016\/j.nefroe.2026.501473_bib0435","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.3399\/BJGP.2022.0145","article-title":"Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study","volume":"73","author":"Sullivan","year":"2023","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.nefroe.2026.501473_bib0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2021.08.010","article-title":"The kidney failure risk equation score and CKD care delivery measures: a cross-sectional study","volume":"4","author":"Ahmed","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.nefroe.2026.501473_bib0445","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1515\/cclm-2024-1082","article-title":"Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"63","author":"Cavalier","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nefroe.2026.501473_bib0450","doi-asserted-by":"crossref","DOI":"10.1177\/2054358118763809","article-title":"Perceived benefits and challenges of a risk-based approach to multidisciplinary chronic kidney disease care: a qualitative descriptive study","volume":"5","author":"Smekal","year":"2018","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12882-019-1269-2","article-title":"Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study","volume":"20","author":"Smekal","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0460","doi-asserted-by":"crossref","DOI":"10.1177\/20543581221118434","article-title":"Death and dialysis following discharge from chronic kidney disease clinic: a retrospective cohort study","volume":"9","author":"Che","year":"2022","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0465","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/11297298221084799","article-title":"Is there a role of the kidney failure risk equation in optimizing timing of vascular access creation in pre-dialysis patients?","volume":"24","author":"Kuningas","year":"2022","journal-title":"J Vasc Access"},{"key":"10.1016\/j.nefroe.2026.501473_bib0470","article-title":"Planning vascular access creation: the promising role of the kidney failure risk equation","volume":"20","author":"Marques da Silva","year":"2023","journal-title":"J Vasc Access"},{"key":"10.1016\/j.nefroe.2026.501473_bib0475","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/ndt\/gfae064","article-title":"Clinical impact of the kidney failure risk equation for vascular access planning","volume":"39","author":"Hahn Lundstr\u00f6m","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501473_bib0480","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae008","article-title":"Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making","volume":"17","author":"Atiquzzaman","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2026.501473_bib0485","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae220","article-title":"Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study","volume":"17","author":"Ingwiller","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2026.501473_bib0490","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ekir.2019.05.009","article-title":"Accuracy of kidney failure risk equation in transplant recipients","volume":"4","author":"Akbari","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2026.501473_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2020.09.004","article-title":"The kidney failure risk equation for prediction of allograft loss in kidney transplant recipients","volume":"2","author":"Chu","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.nefroe.2026.501473_bib0500","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120922627","article-title":"Validation of the kidney failure risk equation in kidney transplant recipients","volume":"7","author":"Tangri","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0505","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ekir.2023.03.008","article-title":"Association of the kidney failure risk equation with high health care costs","volume":"8","author":"Reaven","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nefroe.2026.501473_bib0510","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2215\/CJN.06770521","article-title":"Kidney failure risk equation and cost of care in patients with chronic kidney disease","volume":"17","author":"Prasad","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2026.501473_bib0515","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of CKD","volume":"85","author":"Navaneethan","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2026.501473_bib0520","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jamainternmed.2025.5554","article-title":"Supporting shared decision-making in life-altering kidney therapy decisions for older adults","volume":"185","author":"Saeed","year":"2025","journal-title":"JAMA Intern Med"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:27Z","timestamp":1773838527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2013251426000520"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501473","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing chronic kidney disease care through risk prediction: A review of the kidney failure risk equation","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"501473"}}